Related references
Note: Only part of the references are listed.A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
Joanne Kurtzberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Absence of influence of peripheral blood CD34+and CD3+graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide
Alice Garnier et al.
ANNALS OF HEMATOLOGY (2020)
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia
Pietro Merli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
Lixia Sheng et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
Yuki Imura et al.
JCI INSIGHT (2020)
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Erik Boberg et al.
STEM CELLS TRANSLATIONAL MEDICINE (2020)
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells
Jilu Zhang et al.
LEUKEMIA (2019)
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
David Bastian et al.
FRONTIERS IN IMMUNOLOGY (2019)
Future prospects for CD8+ regulatory T cells in immune tolerance
Lea Flippe et al.
IMMUNOLOGICAL REVIEWS (2019)
Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
Juliana A. P. Godoy et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model
Young-Woo Jeon et al.
STEM CELLS AND DEVELOPMENT (2019)
Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways
Xuhao Ni et al.
CELL DEATH & DISEASE (2019)
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children
Jennifer S. Whangbo et al.
BLOOD ADVANCES (2019)
Human LAP+GARP+FOXP3+ regulatory T cells attenuate xenogeneic graft versus host disease
Huihui Wang et al.
THERANOSTICS (2019)
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease
Jennifer S. Whangbo et al.
BLOOD ADVANCES (2019)
A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the FOXP3 Promoter TATA-Box Motif
Yiwen Zhang et al.
JOURNAL OF IMMUNOLOGY (2018)
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Bruce R. Blazar et al.
BLOOD (2018)
Immune regulation by CD8(+) Treg cells: novel possibilities for anticancer immunotherapy
Shuping Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
Marco Colonna
IMMUNITY (2018)
Regulatory B cell phenotype and mechanism of action: the impact of stimulating conditions
Magdalena Wasik et al.
MICROBIOLOGY AND IMMUNOLOGY (2018)
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C. Betts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Advance in Targeted immunotherapy for Graft-versus-Host Disease
Lingling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease
Supinya Iamsawat et al.
JOURNAL OF IMMUNOLOGY (2018)
Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
Ross E. B. Fitzsimmons et al.
STEM CELLS INTERNATIONAL (2018)
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
Peilong Lai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Genetic engineering of T cells with chimeric antigen receptors for hematological malignancy immunotherapy
Dongdong Ti et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
Elena Gianchecchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
Ying-Jun Chang et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
Sandeep Kumar et al.
FRONTIERS IN IMMUNOLOGY (2018)
New and emerging therapies for acute and chronic graft versus host disease
LaQuisa Hill et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2018)
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease
Danny W. Bruce et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant
Victor Tkachev et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease
Adriana Gutierrez-Hoya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
Yue Hu et al.
ONCOIMMUNOLOGY (2017)
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells
Ana Camelo et al.
BLOOD ADVANCES (2017)
CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study
Sarita Rani Jaiswal et al.
CYTOTHERAPY (2017)
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Frederick L. Locke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD
Elad Jacoby et al.
BLOOD (2016)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
Kazuo Muroi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity
Shuting Zhao et al.
ACS NANO (2016)
Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression
Ludovic Belle et al.
BLOOD (2016)
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner
Cameron McDonald-Hyman et al.
BLOOD (2016)
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
Mehdi Najar et al.
CYTOTHERAPY (2016)
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Katherine G. MacDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation
Min-Jung Park et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Establishing guidelines for CAR-T cells: challenges and considerations
Wei Wang et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in mice
Jessica Heinrichs et al.
ONCOIMMUNOLOGY (2016)
The immunomodulatory function of mesenchymal stem cells: mode of action and pathways
Antonio Uccelli et al.
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE (2015)
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity
Ian B. Copland et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity
Joanna J. Messmann et al.
BLOOD (2015)
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts
Marie Bleakley et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation
Jeffery J. Auletta et al.
STEM CELLS (2015)
Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation
Alessandra Petrelli et al.
TRANSPLANTATION (2015)
Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
Silvia Gregori et al.
FRONTIERS IN IMMUNOLOGY (2015)
Innate protection from graft-versus-host disease
Tom Cupedo
BLOOD (2014)
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
Ahmad Khoder et al.
BLOOD (2014)
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease
J. Marius Munneke et al.
BLOOD (2014)
Increased Th17/Treg ratio in chronic liver GVHD
F. Malard et al.
BONE MARROW TRANSPLANTATION (2014)
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
Ren-Xi Wang et al.
NATURE MEDICINE (2014)
Immunological outcome in haploicentical-HSC transplanted patients treated with IL-10-anergizec donor T Cells
Rosa Bacchetta et al.
FRONTIERS IN IMMUNOLOGY (2014)
Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice
Dapeng Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The Expression of Th17-Associated Cytokines in Human Acute Graft-versus-Host Disease
Yuejun Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Adoptive Transfer of Umbilical Cord Blood-Derived Regulatory T Cells and Early Viral Reactivation
Claudio G. Brunstein et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Jacques Galipeau
CYTOTHERAPY (2013)
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
Sven Malchow et al.
SCIENCE (2013)
CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
Fabian Flores-Borja et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD
Norifumi Sawamukai et al.
BLOOD (2012)
Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation
Renee J. Robb et al.
BLOOD (2012)
Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion
Xuebin Qu et al.
EXPERIMENTAL HEMATOLOGY (2012)
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
Birgit Federmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity
Amy J. Beres et al.
JOURNAL OF IMMUNOLOGY (2012)
IL-10-Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
Abhishek Das et al.
JOURNAL OF IMMUNOLOGY (2012)
The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation
Masatsugu Tanaka et al.
LEUKEMIA RESEARCH (2012)
The immunomodulatory capacity of mesenchymal stem cells
Antje Gebler et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Basic Biology and Clinical Application of Multipotent Mesenchymal Stromal Cells: From Bench to Bedside
Selim Kuci et al.
STEM CELLS INTERNATIONAL (2012)
The role of interleukin-2 during homeostasis and activation of the immune system
Onur Boyman et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism
Dennis B. Leveson-Gower et al.
BLOOD (2011)
Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
Isao Tawara et al.
CLINICAL CANCER RESEARCH (2011)
Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease
Amy Beres et al.
CLINICAL CANCER RESEARCH (2011)
Mesenchymal stem cell inhibition of T-helper 17 cell-differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor
Michelle M. Duffy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Janelle A. Olson et al.
BLOOD (2010)
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
Silvia Gregori et al.
BLOOD (2010)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Development and Function of Myeloid-Derived Suppressor Cells Generated From Mouse Embryonic and Hematopoietic Stem Cells
Zuping Zhou et al.
STEM CELLS (2010)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
Michael A. Pulsipher et al.
BLOOD (2009)
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
Xiao Chen et al.
BLOOD (2009)
Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT
L. M. Ball et al.
BONE MARROW TRANSPLANTATION (2008)
Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease
Andrea T. Badillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
DC activated via dectin-1 convert Treg into IL-17 producers
Fabiola Osorio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation
Tatyana B. Prigozhina et al.
EXPERIMENTAL HEMATOLOGY (2008)
CD8+ suppressor T cells resurrected
Judith A. Kapp et al.
HUMAN IMMUNOLOGY (2008)
NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis
Jay A. Berzofsky et al.
JOURNAL OF IMMUNOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Activation-associated phenotype of CD3+ T cells in acute graft-versus-host disease
M. Paz Morante et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Tr1 cells: From discovery to their clinical application
M Battaglia et al.
SEMINARS IN IMMUNOLOGY (2006)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
E Klyushnenkova et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Share Paper
